HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: P&G/Tambrands

This article was originally published in The Rose Sheet

Executive Summary

P&G/Tambrands: Procter & Gamble to acquire White Plains, N.Y.-based Tambrands and its sole product, Tampax tampons for $1.85 bil., the companies announced April 9. Tambrands, the market leader in the tampon field, reported sales of $662.1 mil. in 1996. Under the deal, Tambrands shareholders will receive $50 per share. P&G said it will fund the acquisition with cash and short-term loans. If approved by shareholders and given Federal Trade Commission clearance, the deal would serve to enhance P&G's already strong feminine protection offerings, which include the pads and pantyliner brands Always and Whisper. P&G plans to increase distribution of Tampax, on the retail and international levels, and increase marketing efforts, the company said. In addition, P&G said it will "improve existing products and develop new ones." At present, Tambrands will continue to operate as a separate business under P&G's paper products division, P&G noted...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS004022

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel